Medical device for retinal autofluorescence
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
200
NCT06400368
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
Phase: N/A
Role: Lead Sponsor
Start: Apr 24, 2024
Completion: Apr 30, 2026
Loading map...